Literature DB >> 29423614

MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein.

Matthias Baumann1, Astrid Grams2, Tanja Djurdjevic2, Eva-Maria Wendel3, Christian Lechner4, Bettina Behring5, Astrid Blaschek6, Katharina Diepold7, Astrid Eisenkölbl8, Joel Fluss9, Michael Karenfort10, Johannes Koch11, Bahadir Konuşkan12, Steffen Leiz13, Andreas Merkenschlager14, Daniela Pohl15, Mareike Schimmel16, Charlotte Thiels17, Barbara Kornek18, Kathrin Schanda19, Markus Reindl19, Kevin Rostásy20.   

Abstract

Antibodies against the myelin oligodendrocyte glycoprotein (MOG-Ab) can be detected in various pediatric acquired demyelinating syndromes (ADS). Here, we analyze the spectrum of neuroradiologic findings in children with MOG-Ab and a first demyelinating event. The cerebral and spinal MRI of 69 children with different ADS was assessed in regard to the distribution and characteristics of lesions. Children with acute disseminated encephalomyelitis (n = 36) or neuromyelitis optica spectrum disorder (n = 5) presented an imaging pattern characterized predominantly by poorly demarcated lesions with a wide supra- and infratentorial distribution. Younger children also tended to have poorly defined and widespread lesions. The majority of patients with an isolated optic neuritis (n = 16) only presented small non-specific brain lesions or none at all. A longitudinally extensive transverse myelitis mainly affecting the cervical, and less often so the thoracic, lumbar, and conus regions, was detected in 31 children. The three children of our cohort who were then finally diagnosed with multiple sclerosis had at onset already demarcated white matter lesions as well as transverse myelitis. In conclusion, children with MOG seropositive ADS present disparate, yet characteristic imaging patterns. These patterns have been seen to correlate to the disease entity as well as to age of symptom onset.

Entities:  

Keywords:  Acute disseminated encephalomyelitis; Magnetic resonance imaging; Multiple sclerosis; Myelin oligodendrocyte glycoprotein; Neuromyelitis optica spectrum disorder; Pediatric acquired demyelinating syndromes

Mesh:

Substances:

Year:  2018        PMID: 29423614     DOI: 10.1007/s00415-018-8781-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  27 in total

1.  Normal white matter development from infancy to adulthood: comparing diffusion tensor and high b value diffusion weighted MR images.

Authors:  Dafna Ben Bashat; Liat Ben Sira; Moshe Graif; Pazit Pianka; Talma Hendler; Yoram Cohen; Yaniv Assaf
Journal:  J Magn Reson Imaging       Date:  2005-05       Impact factor: 4.813

2.  Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis.

Authors:  Kevin Rostasy; Simone Mader; Kathrin Schanda; Peter Huppke; Jutta Gärtner; Verena Kraus; Michael Karenfort; Daniel Tibussek; Astrid Blaschek; Barbara Bajer-Kornek; Steffen Leitz; Mareike Schimmel; Franziska Di Pauli; Thomas Berger; Markus Reindl
Journal:  Arch Neurol       Date:  2012-06

3.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.

Authors:  Sven Jarius; Klemens Ruprecht; Ingo Kleiter; Nadja Borisow; Nasrin Asgari; Kalliopi Pitarokoili; Florence Pache; Oliver Stich; Lena-Alexandra Beume; Martin W Hümmert; Marius Ringelstein; Corinna Trebst; Alexander Winkelmann; Alexander Schwarz; Mathias Buttmann; Hanna Zimmermann; Joseph Kuchling; Diego Franciotta; Marco Capobianco; Eberhard Siebert; Carsten Lukas; Mirjam Korporal-Kuhnke; Jürgen Haas; Kai Fechner; Alexander U Brandt; Kathrin Schanda; Orhan Aktas; Friedemann Paul; Markus Reindl; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2016-09-27       Impact factor: 8.322

4.  Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis.

Authors:  Maciej Jurynczyk; Ruth Geraldes; Fay Probert; Mark R Woodhall; Patrick Waters; George Tackley; Gabriele DeLuca; Saleel Chandratre; Maria I Leite; Angela Vincent; Jacqueline Palace
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

5.  White matter changes in paediatric multiple sclerosis and monophasic demyelinating disorders.

Authors:  Giulia Longoni; Robert A Brown; Parya MomayyezSiahkal; Colm Elliott; Sridar Narayanan; Amit Bar-Or; Ruth Ann Marrie; E Ann Yeh; Massimo Filippi; Brenda Banwell; Douglas L Arnold
Journal:  Brain       Date:  2017-05-01       Impact factor: 13.501

6.  Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica.

Authors:  K Rostásy; S Mader; E M Hennes; K Schanda; V Gredler; A Guenther; A Blaschek; C Korenke; M Pritsch; D Pohl; O Maier; G Kuchukhidze; M Brunner-Krainz; T Berger; M Reindl
Journal:  Mult Scler       Date:  2012-12-20       Impact factor: 6.312

7.  Development of a standardized MRI scoring tool for CNS demyelination in children.

Authors:  L H Verhey; H M Branson; S Laughlin; M M Shroff; S M Benseler; B M Feldman; D L Streiner; J G Sled; B Banwell
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-24       Impact factor: 3.825

8.  Myelin Oligodendrocyte Glycoprotein-Associated Pediatric Central Nervous System Demyelination: Clinical Course, Neuroimaging Findings, and Response to Therapy.

Authors:  Salini Thulasirajah; Daniela Pohl; Jorge Davila-Acosta; Sunita Venkateswaran
Journal:  Neuropediatrics       Date:  2016-04-29       Impact factor: 1.947

9.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

10.  Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children.

Authors:  Yael Hacohen; Michael Absoud; Kumaran Deiva; Cheryl Hemingway; Petra Nytrova; Mark Woodhall; Jacqueline Palace; Evangeline Wassmer; Marc Tardieu; Angela Vincent; Ming Lim; Patrick Waters
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-03-12
View more
  19 in total

Review 1.  [MOG encephalomyelitis: international recommendations on diagnosis and antibody testing].

Authors:  S Jarius; F Paul; O Aktas; N Asgari; R C Dale; J de Seze; D Franciotta; K Fujihara; A Jacob; H J Kim; I Kleiter; T Kümpfel; M Levy; J Palace; K Ruprecht; A Saiz; C Trebst; B G Weinshenker; B Wildemann
Journal:  Nervenarzt       Date:  2018-12       Impact factor: 1.214

2.  Radiological characteristics of myelin oligodendrocyte glycoprotein antibody disease.

Authors:  Sara Salama; Majid Khan; Michael Levy; Izlem Izbudak
Journal:  Mult Scler Relat Disord       Date:  2019-01-10       Impact factor: 4.339

Review 3.  Pediatric Acquired Demyelinating Disorders.

Authors:  J Nicholas Brenton
Journal:  Continuum (Minneap Minn)       Date:  2022-08-01

Review 4.  Imaging in Pediatric Multiple Sclerosis : An Iconographic Review.

Authors:  Gonzalo Barraza; Kumaran Deiva; Béatrice Husson; Catherine Adamsbaum
Journal:  Clin Neuroradiol       Date:  2020-07-16       Impact factor: 3.649

Review 5.  Myelin oligodendrocyte glycoprotein antibodies in neurological disease.

Authors:  Markus Reindl; Patrick Waters
Journal:  Nat Rev Neurol       Date:  2019-02       Impact factor: 42.937

6.  Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS.

Authors:  Samantha A Banks; Padraig P Morris; John J Chen; Sean J Pittock; Elia Sechi; Amy Kunchok; Jan-Mendelt Tillema; James P Fryer; Brian G Weinshenker; Karl N Krecke; A Sebastian Lopez-Chiriboga; Adam Nguyen; Tammy M Greenwood; Claudia F Lucchinetti; Nicholas L Zalewski; Steven A Messina; Eoin P Flanagan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-12-28       Impact factor: 13.654

7.  Identification of TNFAIP3 as relapse biomarker and potential therapeutic target for MOG antibody associated diseases.

Authors:  Shrishti Saxena; Hrishikesh Lokhande; Grace Gombolay; Radhika Raheja; Timothy Rooney; Tanuja Chitnis
Journal:  Sci Rep       Date:  2020-07-24       Impact factor: 4.379

Review 8.  Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders?

Authors:  Franziska Di Pauli; Thomas Berger
Journal:  Front Immunol       Date:  2018-11-29       Impact factor: 7.561

Review 9.  Update on pediatric optic neuritis.

Authors:  Jane H Lock; Nancy J Newman; Valérie Biousse; Jason H Peragallo
Journal:  Curr Opin Ophthalmol       Date:  2019-11       Impact factor: 3.761

Review 10.  MOG encephalomyelitis: international recommendations on diagnosis and antibody testing.

Authors:  S Jarius; F Paul; O Aktas; N Asgari; R C Dale; J de Seze; D Franciotta; K Fujihara; A Jacob; H J Kim; I Kleiter; T Kümpfel; M Levy; J Palace; K Ruprecht; A Saiz; C Trebst; B G Weinshenker; B Wildemann
Journal:  J Neuroinflammation       Date:  2018-05-03       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.